High level of the target antigen was present in both HN5 and the triple negative breast cancer cell line MDA-MB-468, but not in the HER-2 overexpressing breast cancer cell line SKBR-3 (Figure 1, Supplementary Figure 2). This evidence concerns the gene ERBB2 and breast carcinoma.